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background: Multiple myeloma manifests with back pain, anemia and renal failure. It is associated with AL amyloidosis in only 10%-15% of 
patients. Fewer than 5% of patients with AL amyloidosis involving the heart have clinically isolated cardiac disease. Recurrent pleural effusion as a 
manifestation of AL amyloidosis is rare.
case:  A 78-year-old male presented with a three-month history of progressive exertional dyspnea and recurrent right transudative pleural effusions 
that had been tapped twice. Previous medical history was unremarkable. Physical examination showed mildly distended jugular veins, mild bilateral 
pedal edema, and decreased air entry over the lower half of the right lung. Heart sounds were normal without murmurs or gallop. Chest radiography 
revealed a large right pleural effusion without cardiomegaly or pulmonary congestion. ECG was unremarkable. Hemoglobin, renal function, liver 
enzymes and electrolytes were all normal.
Decision-making:  Echocardiography was notable for moderately thickened walls (up to 17mm) and diastolic dysfunction grade 2/4 with 
elevated E/e’ ratio. There was preserved systolic function, mildly dilated left atrium, normal aortic valve, and mild mitral regurgitation. Serum protein 
electrophoresis did not detect a monoclonal band. Serum immunofixation electrophoresis was also negative. Subcutaneous abdominal fat pad 
aspirate stained for amyloid with Congo red was negative. In the absence of hypertension or aortic stenosis to explain the cardiac hypertrophy, AL 
amyloidosis was still considered a likely diagnosis, and therefore a serum free light chain (FLC) assay was performed. This showed a very low kappa/
lambda FLC ratio of 0.07 (normal 0.26-1.65). Bone marrow biopsy immunohistochemical staining and Congo red stain were consistent with multiple 
myeloma and AL amyloidosis.
conclusion: This is a case of restrictive cardiomyopathy with atypical clinical presentation and negative initial work-up for amyloidosis. A high 
index of suspicion for systemic amyloidosis warrants obtaining also a serum FLC assay as it can detect circulating FLC with 10-fold greater sensitivity 
than immunofixation in AL amyloidosis, as exemplified in this patient.
